UNIVERSITY OF VIRGINIA Health System and Novant Health announced their intent to create a Northern Virginia regional health system. The proposed agreement would include UVA Culpeper Hospital and all of Novant Health's Virginia facilities, including Novant Health Haymarket Medical Center, Novant Health Prince William Medical Center and Novant Health Cancer Center. Final details are anticipated to be announced in July 2015.
INDERBIR GILL was appointed chair of global initiatives for the American Urological Association, effective June 1.
KEVIN BEHRNS was named co-editor-in-chief of the journal Surgery, as well as a member of the executive committee of the board of governors of the American College of Surgeons. Behrns is chairman of the University of Florida College of Medicine's department of surgery and the Edward R. Woodward professor of surgery.
SAGAR LONIAL was named chief medical officer, and CHARLES STALEY was named chief quality officer of Winship Cancer Institute of Emory University. Both physicians joined Winship's senior leadership team.
GEOFFREY KIM was named director of the Division of Oncology Products 1 in the FDA Office of Hematology Oncology Products.
THE CENTERS FOR MEDICARE & MEDICAID SERVICES approved the American College of Radiology Lung Cancer Screening Registry as a method for providers to submit data, meet Medicare quality reporting requirements, and receive payment for CT lung cancer screening.
MEMORIAL SLOAN KETTERING Cancer Center partnered with PeraHealth to help improve clinician communication and detect subtle, unexpected patient deterioration. MSK will use PeraHealth's suite of patient monitoring software across its entire health system, including its 21 ambulatory clinics.
FRED HUTCHINSON Cancer Research Center expanded its relationship with Cryoport Inc. to provide cryogenic logistics support to additional labs in its Clinical Research Division.
INDIANA UNIVERSITY School of Medicine and Lilly USA have partnered to form a medical student rotation program focused on drug development. The four-week program is available to third- and fourth-year students.
ANDREW ROBBINS was appointed chief operating officer of Array BioPharma Inc.
